CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis - Top-Institutions - MDSpire

The Role of the CCL20-CCR6 Pathway in Mediating Interactions Between Mucosal-Associated Invariant T Cells and M2 Macrophages Contributing to Immune Dysregulation in Liver Cirrhosis

  • By

  • Bochen Chen

  • Ruoling Li

  • Shuya Zhang

  • Yiting Lou

  • Shuo Zhang

  • Jiaheng Lou

  • Jingcheng Zhang

  • Chuyun Xu

  • Tao Jiang

  • Yuanlin Lv

  • July 20, 2026

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • Hepatology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Gastroenterology
    • Hepatology

Original Source(s)

CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis

  • by Bochen Chen, Ruoling Li, Shuya Zhang, Yiting Lou, Shuo Zhang, Jiaheng Lou, Jingcheng Zhang, Chuyun Xu, Tao Jiang, Yuanlin Lv

  • July 20, 2026

Related Content

MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver?

Hepatic Steatosis Severity Prediction in Nonobese Individuals: Machine Learning Model Development and Validation

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study